A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy AdultsAndrás Nagy, Zhaoyang Li, Leman Yel et al.|Journal of Clinical Immunology|2023Cited by 3
Tolerability and safety of facilitated subcutaneous immunoglobulin 20% in healthy adults: a phase 1 open-label studyAndrás Nagy, Zhaoyang Li, Juan Carlos Rondón et al.|Clinical Immunology|2023Cited by 0